Stock Comparison

BBIO vs VRTX

BridgeBio Pharma Inc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

BBIO

BridgeBio Pharma Inc

Healthcare

VRTX

Vertex Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$15.87B

$123.94B

P/E (TTM)

—

28.5

Forward P/E

—

25.7

Price/Sales

27.4

9.9

Price/Book

118.6

6.1

EV/EBITDA

-9.0

23.2

Dividend Yield

—

Profitability

Net Margin

-102.70%

35.40%

Operating Margin

-80.17%

38.97%

Return on Equity

-1790.00%

23.50%

Return on Assets

-28.00%

11.90%

Growth (YoY)

Revenue Growth

66.80%

12.50%

Earnings Growth

0.00%

8.00%

Price & Risk

Beta

1.0

0.3

52-Week High

$90.17

$529.65

52-Week Low

$47.29

$376.62

Analyst Target

$106.19

$559.28

Compare BBIO and VRTX your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.